Clinical Trials Directory

Trials / Completed

CompletedNCT05746494

The Efficacy of Neural Stimulation in Individuals With Schizophrenia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
The University of Texas at Dallas · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to understand the relationship between psychotic symptoms and social functioning in individuals with schizophrenia spectrum disorders. Our goal is to determine whether stimulating the brain using transcranial Direct Current Stimulation (tDCS) can improve symptoms and daily functioning.

Detailed description

Paranoid ideation is a common delusion experienced by individuals with schizophrenia spectrum disorders (SSD) that negatively impacts social interactions and quality of life. Therefore, efforts to reduce paranoid thinking via neuromodulation techniques \[e.g., transcranial direct current stimulation (tDCS)\] are in development, with amygdala-prefrontal cortex (PFC) circuits targeted as critical components of the neural mechanisms underlying paranoia. This project aims to alleviate paranoia and improve social functioning in individuals with SSD by implementing tDCS to ventrolateral PFC. A double-blind, within-subjects, crossover design will be used to compare the effects of active vs. sham tDCS. Ecological Momentary Assessments (EMA) will also be utilized to quantify any delayed stimulation effects in daily social interactions.

Conditions

Interventions

TypeNameDescription
DEVICEtDCSactive anodal tDCS and sham tDCS

Timeline

Start date
2022-11-21
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2023-02-27
Last updated
2025-02-26
Results posted
2025-02-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05746494. Inclusion in this directory is not an endorsement.